NPPB and coronary artery disorder: In addition, the incidence of ARB treatment in the CAD group was significantly higher than that in the non-CAD group, whereas there were no differences in BP, HR, left ventricular ejection fraction (LVEF), eGFR or blood levels of NT-proBNP (Table 2).